Toggle light / dark theme

AI leaders have a new term for the fact that their models are not always so intelligent

Progress is rarely linear, and AI is no exception.

As academics, independent developers, and the biggest tech companies in the world drive us closer to artificial general intelligence — a still hypothetical form of intelligence that matches human capabilities — they’ve hit some roadblocks. Many emerging models are prone to hallucinating, misinformation, and simple errors.

Google CEO Sundar Pichai referred to this phase of AI as AJI, or “artificial jagged intelligence,” on a recent episode of Lex Fridman’s podcast.

Securing Your Airspace: Detection of Drones Trespassing Protected Areas

Unmanned Aerial Vehicle (UAV) deployment has risen rapidly in recent years. They are now used in a wide range of applications, from critical safety-of-life scenarios like nuclear power plant surveillance to entertainment and hobby applications…

Wuhan’s AI Development

Wuhan, China’s inland metropolis, is paving the way for a nationwide rollout of “embodied” artificial intelligence meant to fast-track scientific discovery, optimize production, streamline commerce, and facilitate state supervision of social activities. Grounded in real-world data, the AI grows smarter, offering a pathway to artificial “general” intelligence that will reinforce state ideology and boost economic goals. This report documents the genesis of Wuhan’s AGI initiative and its multifaceted deployment.

Artificial intelligence in prostate cancer

Artificial intelligence (A.I.) has recently become a buzzword in so many aspects of our lives, but it has been used to some degree in health care for a while. One area of health care where A.I. has made significant strides is the diagnosis and treatment of prostate cancer.

“We are just at the tip of the iceberg of utilizing A.I. for prostate cancer,” says Dr. David D. Yang, a radiation oncologist with Harvard-affiliated Brigham and Women’s Hospital and Dana-Farber Cancer Institute. “So far, it has been shown to help improve the care for men with prostate cancer in limited, yet effective ways.”

Agility Robotics CEO & Digit Show us Robots at Work

Peggy Johnson, CEO of Agility Robotics, discusses how humanoid robots like Digit are transforming logistics and manufacturing. She speaks with Bloomberg Businessweek’s Brad Stone about the rapid advances in automation and the next era of robots in the workplace at Bloomberg Tech in San Francisco. (Source: Bloomberg)